Insights

Growing Industry Presence Nusano has actively participated in prominent industry events like the Utah Life Sciences Summit and received the Innovation Impact Award, positioning itself as a recognized leader in biotech innovation and offering opportunities for collaboration and strategic partnerships.

Strategic Expansion The company recently expanded its high-tech facilities in West Valley City, Utah, with plans to commence operations in late 2025. This expansion indicates a readiness to scale isotope production, presenting opportunities to supply industries and healthcare providers with high-demand radioisotopes.

Innovative Technology Nusano leverages proprietary ion source technology for sustainable isotope production, making it an attractive partner for organizations seeking reliable and environmentally friendly sources of medical and industrial isotopes.

Strong Financial Position With revenues estimated between $50 million and $100 million and funding of $115 million, Nusano demonstrates solid financial backing, suggesting capacity for long-term supply commitments and collaborative ventures in isotopes and radiotherapeutics.

Partnership Opportunities Nusano's recent multi-year supply agreement with Cellectar Biosciences and its focus on developing isotopes like copper-67 highlight potential for sales collaborations in radiotherapeutics and rare isotope markets, appealing to healthcare providers and biotech firms seeking reliable isotope sources.

Similar companies to Nusano

Nusano Tech Stack

Nusano uses 8 technology products and services including Microsoft Clarity, HubSpot Analytics, iCIMS, and more. Explore Nusano's tech stack below.

  • Microsoft Clarity
    Analytics
  • HubSpot Analytics
    Analytics
  • iCIMS
    Applicant Tracking Systems
  • Epicor Kinetic
    Enterprise Resource Planning
  • jQuery
    Javascript Libraries
  • iOS
    Programming Languages
  • PHP
    Programming Languages
  • Web Font Loader
    Web Fonts

Nusano's Email Address Formats

Nusano uses at least 1 format(s):
Nusano Email FormatsExamplePercentage
First.Last@nusano.comJohn.Doe@nusano.com
50%
First@nusano.comJohn@nusano.com
1%
First.Last@nusano.comJohn.Doe@nusano.com
49%

Frequently Asked Questions

What is Nusano's official website and social media links?

Minus sign iconPlus sign icon
Nusano's official website is nusano.com and has social profiles on LinkedInCrunchbase.

What is Nusano's SIC code NAICS code?

Minus sign iconPlus sign icon
Nusano's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nusano have currently?

Minus sign iconPlus sign icon
As of December 2025, Nusano has approximately 181 employees across 1 continents, including North America. Key team members include Chief Executive Officer: C. L.Chief Executive Officer: N. W.Chief Commercial Officer (cco): R. J.. Explore Nusano's employee directory with LeadIQ.

What industry does Nusano belong to?

Minus sign iconPlus sign icon
Nusano operates in the Biotechnology Research industry.

What technology does Nusano use?

Minus sign iconPlus sign icon
Nusano's tech stack includes Microsoft ClarityHubSpot AnalyticsiCIMSEpicor KineticjQueryiOSPHPWeb Font Loader.

What is Nusano's email format?

Minus sign iconPlus sign icon
Nusano's email format typically follows the pattern of First.Last@nusano.com. Find more Nusano email formats with LeadIQ.

How much funding has Nusano raised to date?

Minus sign iconPlus sign icon
As of December 2025, Nusano has raised $115M in funding. The last funding round occurred on Oct 01, 2024 for $115M.

Nusano

Biotechnology ResearchUtah, United States51-200 Employees

At Nusano, we believe in the power of innovation to enhance lives and strengthen the communities we serve. We are more than a physics company; we are pioneers in the production of both medical and industrial isotopes. Our mission is to ensure that high-quality radioisotopes are readily available for critical applications ranging from cancer treatment and advancing space exploration, to reducing nuclear waste and enabling alternative energy applications.
 
Our state-of-the-art facility in West Valley City, Utah will harness our proprietary ion source technology to produce isotopes efficiently and sustainably. We understand the urgent need for reliable access to these vital resources, and we are committed to leading the way in supply stability and innovation. We envision a future where no patient has to face treatment delays due to shortages, and where industries can thrive with dependable access to the materials they need.
 
At Nusano, we are dedicated to making a meaningful impact, not only in healthcare but also in the broader community. We strive to empower our partners and customers, ensuring that together, we can build a healthier, more vibrant tomorrow for all.

Section iconCompany Overview

Website
nusano.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $115M

    Nusano has raised a total of $115M of funding over 2 rounds. Their latest funding round was raised on Oct 01, 2024 in the amount of $115M.

  • $50M$100M

    Nusano's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $115M

    Nusano has raised a total of $115M of funding over 2 rounds. Their latest funding round was raised on Oct 01, 2024 in the amount of $115M.

  • $50M$100M

    Nusano's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.